Walleye Capital’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

Walleye Capital’s Portfolio LVACU Stock Details LVACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-30,226	Closed	-$315K	–	5211
2023 Q1	$315K	Hold	30,226	–	–	﹤0.01%	2084
2022 Q4	$309K	Hold	30,226	–	–	0.01%	1764
2022 Q3	$304K	Hold	30,226	–	–	0.01%	1832
2022 Q2	$303K	Buy	30,226 +200	+0.7%	+$2.01K	0.01%	1316
2022 Q1	$303K	Sell	30,026 -65,974	-69%	-$667K	0.01%	1306
2021 Q4	$968K	Buy	+96,000	New	+$971K	0.03%	617

Walleye Capital's LVACU Position: Q2 2023 in Review

Walleye Capital sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q2 2023, closing a stake of 30,226 shares — an estimated $315K sold.

Walleye Capital first reported a position in LVACU in Q4 2021 and held it in 6 quarters. The position peaked at $968K in Q4 2021. 0 funds tracked by Wall St. Rank hold LVACU as of Q2 2023.

Walleye Capital reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q2 2023 after selling out during the quarter.
Walleye Capital sold 30,226 LAVA Medtech Acquisition Corp. Unit shares in Q2 2023, an estimated $315K.
Walleye Capital first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 6 quarters.
Walleye Capital's LAVA Medtech Acquisition Corp. Unit position peaked at $968K in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q2 2023.

Based on Walleye Capital's 13F filing for Q2 2023, filed 14 Aug 2023.